骨纤维结构不良样造釉细胞瘤与经典型造釉细胞瘤的手术结局与肿瘤学生存:318例国际多中心研究
该回顾性多中心队列研究纳入1985至2015年间22家三级骨肿瘤中心治疗的318例骨纤维结构不良样造釉细胞瘤(OFD-AD,128例)和经典型造釉细胞瘤(AD,190例),分析疾病特征与肿瘤学结局。局部复发率OFD-AD为22%、AD为24%,转移和死亡仅见于AD组(分别为18%和11%)。多变量分析显示未污染切除缘(HR=0.164)、病理性骨折(HR=1.968)和性别(女性vs男性HR=0.535)影响局部复发风险。
要点
- OFD-AD局部复发率22%且无转移,支持将其重新归类为中间型局部侵袭性肿瘤。
- AD组转移率18%、死亡率11%,OFD-AD组无转移或死亡。
- 未污染切除缘与局部复发风险降低相关(HR=0.164,95%CI 0.092-0.290,p<0.001)。
核心结论
- OFD-AD和AD属于同一疾病谱但应视为不同实体。
- 基于OFD-AD局部复发率22%且无转移,作者支持将其重新归类为中间型局部侵袭性类别。
- 本研究中转移性疾病仅局限于AD组(发生率18%)。
- 作者主张对OFD-AD和AD均行广泛切除并达到未污染边缘,包括骨和受累骨膜。
研究设计与样本
- 回顾性多中心队列研究,纳入1985年至2015年间22家三级骨肿瘤中心提交的318例经确认的OFD-AD和AD病例。
- 采用单变量和多变量Cox回归分析评估局部复发的临床风险因素,包括大小、类型和边缘。
主要发现
- 318例中OFD-AD 128例、AD 190例;诊断时平均年龄OFD-AD为17岁(中位14.5岁),AD为32岁(中位28岁);53%的患者为女性。
- OFD-AD和AD组合并的平均肿瘤大小为7.8 cm(组织学测量);16%的患者在治疗前发生病理性骨折。
- 局部复发率OFD-AD为22%、AD为24%;OFD-AD组无复发病例进展为AD。
- AD组转移率18%、死亡率11%;OFD-AD组无转移或死亡报告。
- 多变量Cox回归显示未污染切除缘(HR=0.164,95%CI 0.092-0.290,p<0.001)、病理性骨折(HR=1.968,95%CI 1.076-3.600,p=0.028)和性别(女性vs男性:HR=0.535,95%CI 0.300-0.952,p=0.033)影响局部复发风险。
临床怎么用
- 作者主张对OFD-AD和AD均行广泛切除并达到未污染边缘,包括骨和受累骨膜。
- 作者支持将OFD-AD重新归类为中间型局部侵袭性类别,基于局部复发率22%且无转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteofibrous dysplasia-like adamantinoma (OFD-AD) and classic adamantinoma (AD) are rare, neoplastic diseases with only limited data supporting current treatment protocols. We believe that our retrospective multicenter cohort study is the largest analysis of patients with adamantinoma to date. The primary purpose of this study was to describe the disease characteristics and evaluate the oncological outcomes. The secondary purpose was to identify risk factors for local recurrence after surgical treatment and propose treatment guidelines. METHODS: Three hundred and eighteen confirmed cases of OFD-AD and AD for which primary treatment was carried out between 1985 and 2015 were submitted by 22 tertiary bone tumor centers. Proposed clinical risk factors for local recurrence such as size, type, and margins were analyzed using univariable and multivariate Cox regression analysis. RESULTS: Of the 318 cases, 128 were OFD-AD and 190 were AD. The mean age at diagnosis was 17 years (median, 14.5 years) for OFD-AD and 32 years (median, 28 years) for AD; 53% of the patients were female. The mean tumor size in the OFD-AD and AD groups combined was 7.8 cm, measured histologically. Sixteen percent of the patients sustained a pathological fracture prior to treatment. Local recurrence was recorded in 22% of the OFD-AD cases and 24% of the AD cases. None of the recurrences in the OFD-AD group progressed to AD. Metastatic disease was found in 18% of the AD cases and fatal disease, in 11% of the AD cases. No metastatic or fatal disease was reported in the OFD-AD group. Multivariate Cox regression analysis demonstrated that uncontaminated resection margins (hazard ratio [HR] = 0.164, 95% confidence interval [CI] = 0.092 to 0.290, p < 0.001), pathological fracture (HR = 1.968, 95% CI = 1.076 to 3.600, p = 0.028), and sex (female versus male: HR = 0.535, 95% CI = 0.300 to 0.952, p = 0.033) impacted the risk of local recurrence. CONCLUSIONS: OFD-AD and AD are parts of a disease spectrum but should be regarded as different entities. Our results support reclassification of OFD-AD into the intermediate locally aggressive category, based on the local recurrence rate of 22% and absence of metastases. In our study, metastatic disease was restricted to the AD group (an 18% rate). We advocate wide resection with uncontaminated margins including bone and involved periosteum for both OFD-AD and AD. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Schutgens EM, Picci P, Baumhoer D, et al. Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases. J Bone Joint Surg Am. 2020. PMID: 33027124. doi:10.2106/JBJS.19.01056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。